Barry Berkowitz, Ph.D.
University of California, San Francisco. Adjunct Professor of Pharmacology. Founder, Chairman, and Chief Executive Officer, Strong Pharma, LLC. Strong has founded several companies including: Myco/ChemGenics, Fibrogen and New Chemical Entities (sold to Albany Molecular). Strong is currently organizing a new company which utilizes a compelling and novel business model to increase the efficiency of and accelerate drug development.
Marion Kasaian, Ph.D.
Case Western Reserve University. Adjunct Associate Professor of Pharmacology. Principal Research Scientist IV, Inflammation and Immunology, Pfizer Global Biotherapeutic Technologies, Pfizer, Inc., Cambridge, MA.
Research interests: Cellular and innate immune mechanisms contributing to inflammatory diseases, with a focus on asthma.
John C. McKew, Ph.D.
University of California, Davis. Adjunct Associate Professor of Pharmacology. Chief, Therapeutics Development Branch, Center for Translational Therapeutics, National Institutes of Health, Bethesda, MD.
Research Interests:Research interests include medicinal chemistry, synthetic methodology and tool compounds to probe biology. This research has been directed against targets in Inflammation, Cardiovascular, Metabolic Disease, and Muscle Biology.
Oberlin College; M.D. Boston University School of Medicine, Ph.D. Boston University. Adjunct Associate Professor of Pharmacology, School of Medicine; Professor of Anaethesia, Harvard Medical School.
Research Interests: the pharmacokinetics and pharmacodynamics of opioids and sedative hypnotic drugs.
Washington State University. Adjunct Professor of Pharmacology. Chief Scientific Officer, NKT Therapeutics, Inc., Waltham, MA.
Research Interests:Current research interests are directed to two areas: one is on the role of platelets and leukocytes in the pathophysiology of peripheral circulatory disease and thrombosis. The other is the identification of new treatments for coagulation deficiencies like hemophilia A, hemophilia B and other rare bleeding disorders.
Cara M. M. Williams, Ph.D.
University of Liverpool.
Adjunct Associate Professor of Pharmacology. Director of Translational Pharmacology, Inflammation and Remodeling Research Unit, Pfizer Biotherapeutics R & D in Cambridge, Massachusetts.
Clive Wood, Ph.D.
Imperial College, London. Adjunct Professor of Pharmacology. Senior Vice President and Head, Global Biologics, Global Drug Discovery, Bayer Schering Pharma AG in Wuppertal, Germany;
Discovery and preclinical development of innovative therapeutics for inflammation and oncology. Current areas of focus include antibody and small protein-based inhibitors of proteases.